More hospitals dossis blood clot removal system:
This article was originally published in Clinica
Executive Summary
The FDA has allowed three more hospitals to take part in clinical trials of Possis Medical's AngioJet rapid thrombectomy system. The study involves the treatment of ten carotid stroke patients using the US company's blood clot removal system. The device is is indicated for treating all blood vessels of any size throughout the body.